Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

2.

Cystatin C levels in sera of patients with acute infectious diseases with high C-reactive protein levels.

Randers E, Kornerup K, Erlandsen EJ, Hasling C, Danielsen H.

Scand J Clin Lab Invest. 2001 Jul;61(4):333-5. No abstract available.

PMID:
11465348
3.

Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function.

Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H.

Clin Nephrol. 2000 Sep;54(3):203-9.

PMID:
11020018
4.
5.

Spine deformity index in osteoporotic women: relations to forearm and vertebral bone mineral measurements and to iliac crest ash density.

Søgaard CH, Hermann AP, Hasling C, Mosekilde L, Mosekilde L.

Osteoporos Int. 1994 Jul;4(4):211-9.

PMID:
7949751
7.

Marked changes in iliac crest bone structure in postmenopausal osteoporotic patients without any signs of disturbed bone remodeling or balance.

Steiniche T, Christiansen P, Vesterby A, Hasling C, Ullerup R, Mosekilde L, Melsen F.

Bone. 1994 Jan-Feb;15(1):73-9.

PMID:
8024855
9.

Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.

Charles P, Hasling C, Risteli L, Risteli J, Mosekilde L, Eriksen EF.

Calcif Tissue Int. 1992 Dec;51(6):406-11.

PMID:
1451006
10.

Calcium metabolism in postmenopausal osteoporotic women is determined by dietary calcium and coffee intake.

Hasling C, Søndergaard K, Charles P, Mosekilde L.

J Nutr. 1992 May;122(5):1119-26.

PMID:
1564564
11.

Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis.

Hasling C, Eriksen EF, Melkko J, Risteli L, Charles P, Mosekilde L, Risteli J.

J Bone Miner Res. 1991 Dec;6(12):1295-300.

PMID:
1724340
12.

Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

Naeraa RW, Brixen K, Hansen RM, Hasling C, Mosekilde L, Andresen JH, Charles P, Nielsen J.

Calcif Tissue Int. 1991 Aug;49(2):77-83.

PMID:
1913298
13.

Dermal, intestinal, and renal obligatory losses of calcium: relation to skeletal calcium loss.

Charles P, Eriksen EF, Hasling C, Søndergård K, Mosekilde L.

Am J Clin Nutr. 1991 Jul;54(1 Suppl):266S-273S. Review.

PMID:
2053572
14.
15.

Calcium metabolism in postmenopausal osteoporosis: the influence of dietary calcium and net absorbed calcium.

Hasling C, Charles P, Jensen FT, Mosekilde L.

J Bone Miner Res. 1990 Sep;5(9):939-46.

PMID:
2281824
16.

A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.

Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F.

Bone. 1989;10(5):313-20.

PMID:
2690898
17.

[Serum parathyroid hormone (1-84) assessed by immunoradiometric methods can differentiate malignant hypercalcemia and primary hyperparathyroidism].

Laurberg P, Charles P, Hasling C, Mosekilde L, Nielsen HK.

Ugeskr Laeger. 1988 Nov 28;150(48):2972-4. Danish. No abstract available.

PMID:
3201618
18.
19.

Etidronate disodium in the management of malignancy-related hypercalcemia.

Hasling C, Charles P, Mosekilde L.

Am J Med. 1987 Feb 23;82(2A):51-4.

PMID:
3103436
20.

Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D.

Hasling C, Nielsen HE, Melsen F, Mosekilde L.

Miner Electrolyte Metab. 1987;13(2):96-103.

PMID:
3696093

Supplemental Content

Loading ...
Support Center